Stay updated on KPT-8602 Safety & Efficacy in Refractory Cancer Clinical Trial
Sign up to get notified when there's something new on the KPT-8602 Safety & Efficacy in Refractory Cancer Clinical Trial page.

Latest updates to the KPT-8602 Safety & Efficacy in Refractory Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedA new revision entry, v3.7.0, was added to the study record history, and the previous revision, v3.6.6, was removed. This update reflects an update to the record's version history.SummaryDifference0.1%

- Check39 days agoChange DetectedRevision: v3.6.6 is shown in the page footer, replacing the previous v3.6.5. This indicates a minor site update and does not change the study data or how the history page works.SummaryDifference0.1%

- Check60 days agoChange DetectedThe record history now shows a new revision tag v3.6.5, replacing v3.6.4, indicating an updated version entry in the page's history.SummaryDifference0.1%

- Check75 days agoChange DetectedThe record history now shows a new revision entry 'Revision: v3.6.4' and removes the previous 'Revision: v3.6.3', updating the historical record for the page. This reflects an internal update to the page's revision tracking.SummaryDifference0.1%

- Check96 days agoChange DetectedThe page's revision line updated from v3.6.2 to v3.6.3, indicating a newer version of the study history page. This change reflects an incremental metadata update rather than any modification to the study data or user-facing features.SummaryDifference0.1%

- Check104 days agoChange DetectedThe record history adds a new revision entry indicating the page is now at version v3.6.2, replacing the previous v3.6.0. This reflects an internal update to the page template or system rather than a change to the study data.SummaryDifference0.1%

Stay in the know with updates to KPT-8602 Safety & Efficacy in Refractory Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the KPT-8602 Safety & Efficacy in Refractory Cancer Clinical Trial page.